Medicine Atlas

How Healing Is Practiced
Sign In
Text size
100%
Theme
Treatment

Tubal Ligation

Surgical Procedure

Tubal ligation, commonly known as having one's tubes tied, is a surgical procedure for female sterilization in which the fallopian tubes are permanently blocked, clipped or removed, preventing sperm from fertilizing an egg and an embryo from implanting. It is the female counterpart to vasectomy and is treated by the United States Food and Drug Administration as a permanent method of sterilization and birth control. As with other forms of sterilization, only the consent of the patient herself, not a partner, spouse or family member, is required for the procedure.

Facts
Classification
Status
Standard of Care 1
Origin Year
1880 2
FAQs

Has research found that tubal ligation changes ovarian reserve?

One small study found anti-Müllerian hormone fell after tubal ligation by a similar amount whichever procedure was used.

One prospective study of women who had tubal ligation at the end of pregnancy used anti-Müllerian hormone to determine ovarian reserve. The mean anti-Müllerian hormone level fell by 37.83 percent in the group sterilized at cesarean delivery and by 44.15 percent in the group sterilized by laparoscopy after delivery. The percentage changes were not statistically significantly different between the two groups.
Connections

Treats

Source Tubal Ligation (Wikipedia)
Sources
1. Wikipedia
Wikipedia contributors, Wikimedia Foundation
2. Tubal Ligation (Wikipedia)
Wikimedia Foundation
  • Wikipedia Tubal ligation, History section
    The first modern female sterilization procedure was performed in 1880 by Dr. Samuel Lungren of Toledo, Ohio, in the United States.
  • https://en.wikipedia.org/wiki/Tubal_ligation, lead section
    Tubal ligation (commonly known as having one's "tubes tied") is a surgical procedure for female sterilization in which the fallopian tubes are permanently blocked, clipped or removed.
  • Treats: Fallopian Tube Cancer, Medical uses
    Less commonly, tubal ligation procedures may also be performed for patients who are known to be carriers of mutations in genes that increase the risk of ovarian and fallopian tube cancer, such as BRCA1 and BRCA2.
View the Source
Comments (0)
No comments yet. Be the first to share a thought.
Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.

View At A Past Year

Choose a year to see this entry's facts and connections as the atlas records them at that moment: what it held then, what it held instead, and what it had not yet adopted. Choose Present for the current record.